Amir Schori - Endymed Ltd Insider

ENDY -- Israel Stock  

ILS 188.90  14.10  8.07%

Vice President - Business Development

Mr. Amir Schori will no longer serve as Vice President Business Development at Endymed Ltd. effective March 16, 2018. He held this role from April 27, 2014. Additionally, he will not hold this role at the Subsidiary, Endymed Medical. His work experience includes the following roles Sales and Business Development Manager at SodaStream Ltd. and Marketing Manager at SodaStream Ltd.
Age: 42  President Since 2014      
972 4 630 9100
Schori holds a Bachelor of Business Administration degree from the Michlala Leminhal.

Management Efficiency

The company has return on total asset (ROA) of (17.02) % which means that it has lost $17.02 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (101.87) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 163 K in total debt with debt to equity ratio (D/E) of 12.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Endymed Ltd has Current Ratio of 1.26 suggesting that it is not liquid enough and may have problems to pay out its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Endymed Ltd., a medical technology company, designs, develops, and commercializes energy based aesthetic treatment systems for the professional markets. Endymed Ltd. was founded in 2007 and is based in Caesarea, Israel. Endymed Ltd operates under Medical Devices classification in Israel and traded on Tel Aviv Stock Exchange.Endymed Ltd (ENDY) is traded on Tel Aviv Stock Exchange in Israel. It is located in 12 Leshem Street and employs 10 people.

Endymed Ltd Leadership Team

Amir Schori, President
Lee Gabay, Executive
Ben Feldman, CFO, MBA
Yoram Hert, CEO, Ph.D
Amiram Goldman, Director
Eran Naor, Director
Ronen Zadok, Director
Amy Kamin, CEO
Elad Magal, CEO
Yoram Harth, Director, Ph.D
Yuan Yibing, Director
Batsheva Elran, Director, MBA
Oren Maymon, President
Lior Cohen, President
Yosef BarOn, CEO
Atzmon Shlush, President
Eran Ishay, President, MBA
Jan Jingran, Director, Ph.D
Sharon Dovev, Director
Lior Vider, Director
Daniel Lishinsky, President
Idan Alfa, Director
Yocheved Dvir, Director
Annie Jin, Director
Lee Roth, Director
Zvika Lifschitz, President, MBA
Ofer Zvi, Director
Daniel Lischinsky, Founder
Moshe Cohen, Executive

Stock Performance Indicators

Current Sentiment - ENDY

Endymed Ltd Investor Sentiment
Macroaxis portfolio users are insensible in their opinion about investing in Endymed Ltd. What is your opinion about investing in Endymed Ltd? Are you bullish or bearish?
50% Bullish
50% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Endymed Ltd and Bezeq The Israel. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see Investing Opportunities. Please also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.